| Abstract |
Three novel potentially site-activated multitarget tacrine-(hydroxybenzoyl-pyridone) (TAC-HBP) hybrids were designed, synthesized and evaluated as acetylcholinesterase (AChE) inhibitors, antioxidants and biometal chelators. All of them are dual-binding site AChE inhibitors with activity in sub-micromolar range (IC50 = 0.57-0.78 mu M), which is comparable to the parent tacrine, and have good 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging capacity (EC50 = 204-249 mu M) conferred by the hydroxybenzoyl-pyridone (HBP) moiety. Their chelating capacity towards redox-active and/or amyloid-beta-binding metal ions (Fe(III), Cu(II)), Zn(II)) was evaluated by using 2 -hydroxy-4 -methoxybenzoyl-2-pyridone derivative as a model compound in 30\% w/w DMSO/water medium. It was proved that the HBP moiety acts as a moderate/good chelator of these biometals (pFe = 13.9, pCu = 6.0 and pZn = 6.0 at pH 6.0, CL/CM = 10, CM = 10(-6)M), being able to form complexes with beta-coordination mode, and that this chelating ability is preserved in the TAC-HBP hybrids. (C) 2016 Elsevier Inc All rights reserved. |
